nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts
|
|
|
2002 |
|
S |
p. S1-S29 29 p. |
artikel |
2 |
A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679
|
Gosset, James R. |
|
2017 |
|
S |
p. S161-S167 7 p. |
artikel |
3 |
A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores
|
Korell, Julia |
|
2017 |
|
S |
p. S154-S160 7 p. |
artikel |
4 |
Allometric size: The scientific theory and extension to normal fat mass
|
Holford, Nick H.G. |
|
2017 |
|
S |
p. S59-S64 6 p. |
artikel |
5 |
Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts
|
Visser, Sandra A.G. |
|
2017 |
|
S |
p. S72-S77 6 p. |
artikel |
6 |
Author Index
|
|
|
2003 |
|
S |
p. S43-S46 4 p. |
artikel |
7 |
Author Index
|
|
|
2002 |
|
S |
p. S139-S147 9 p. |
artikel |
8 |
Author Index
|
|
|
2004 |
|
S |
p. S79-S82 4 p. |
artikel |
9 |
Biomarkers in epilepsy–A modelling perspective
|
van Dijkman, Sven C. |
|
2017 |
|
S |
p. S47-S52 6 p. |
artikel |
10 |
Calendar of Events
|
|
|
2017 |
|
S |
p. I- 1 p. |
artikel |
11 |
Combined proportional and additive residual error models in population pharmacokinetic modelling
|
Proost, Johannes H. |
|
2017 |
|
S |
p. S78-S82 5 p. |
artikel |
12 |
Diurnal variation in the pharmacokinetics and brain distribution of morphine and its major metabolite
|
Kervezee, Laura |
|
2017 |
|
S |
p. S132-S139 8 p. |
artikel |
13 |
Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet
|
Helmlinger, Gabriel |
|
2017 |
|
S |
p. S39-S46 8 p. |
artikel |
14 |
Drugs in space: Pharmacokinetics and pharmacodynamics in astronauts
|
Kast, Johannes |
|
2017 |
|
S |
p. S2-S8 7 p. |
artikel |
15 |
Editorial Board
|
|
|
2002 |
|
S |
p. IFC- 1 p. |
artikel |
16 |
Editorial Board
|
|
|
2003 |
|
S |
p. IFC- 1 p. |
artikel |
17 |
Editorial board members
|
|
|
2017 |
|
S |
p. IFC- 1 p. |
artikel |
18 |
Editorial Board Page
|
|
|
2004 |
|
S |
p. ii- 1 p. |
artikel |
19 |
Editorial Special Supplement of the European Journal of Pharmaceutical Sciences on the occasion of the retirement of Professor Meindert Danhof as Professor of Pharmacology at Leiden University
|
Burggraaf, Koos |
|
2017 |
|
S |
p. S1- 1 p. |
artikel |
20 |
EUFEPS 2004 New Safe Medicines: Towards Mechanistic Prediction “Building European Science Networks and Opportunities”
|
|
|
2004 |
|
S |
p. vii-xi nvt p. |
artikel |
21 |
Evidence-based drug treatment for special patient populations through model-based approaches
|
Krekels, Elke H.J. |
|
2017 |
|
S |
p. S22-S26 5 p. |
artikel |
22 |
Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma
|
Solms, Alexander |
|
2017 |
|
S |
p. S149-S153 5 p. |
artikel |
23 |
Genotype-guided dosing of warfarin through modeling and simulation
|
Deng, Jiexin |
|
2017 |
|
S |
p. S9-S14 6 p. |
artikel |
24 |
Grupp 3. Pharmaceutical analysis
|
|
|
2002 |
|
S |
p. S47-S57 11 p. |
artikel |
25 |
Grupp 1. Pharmaceutical - medicinal chemistry
|
|
|
2002 |
|
S |
p. S31-S39 9 p. |
artikel |
26 |
Grupp 6. Pharmaceutical technology - pharmaceutics - biopharmaceutics drug absorption
|
|
|
2002 |
|
S |
p. S87-S138 52 p. |
artikel |
27 |
Grupp 2. Pharmacognocy
|
|
|
2002 |
|
S |
p. S41-S45 5 p. |
artikel |
28 |
Grupp 4. Pharmacokinetics and metabolism
|
|
|
2002 |
|
S |
p. S59-S75 17 p. |
artikel |
29 |
Grupp 5. Pharmacology - clinical pharmacology - pharmacovigilance
|
|
|
2002 |
|
S |
p. S77-S85 9 p. |
artikel |
30 |
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development
|
Dingemanse, Jasper |
|
2017 |
|
S |
p. S53-S58 6 p. |
artikel |
31 |
Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine
|
Kohler, Isabelle |
|
2017 |
|
S |
p. S15-S21 7 p. |
artikel |
32 |
Lectures
|
|
|
2003 |
|
S |
p. S3-S17 15 p. |
artikel |
33 |
Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation
|
Völler, Swantje |
|
2017 |
|
S |
p. S90-S97 8 p. |
artikel |
34 |
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
|
Mizuno, Tomoyuki |
|
2017 |
|
S |
p. S124-S131 8 p. |
artikel |
35 |
New Safe Medicines Faster
|
|
|
2002 |
|
S |
p. vii-xi nvt p. |
artikel |
36 |
Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology
|
Allegaert, Karel |
|
2017 |
|
S |
p. S27-S31 5 p. |
artikel |
37 |
Open innovation: Towards sharing of data, models and workflows
|
Conrado, Daniela J. |
|
2017 |
|
S |
p. S65-S71 7 p. |
artikel |
38 |
Oral Communications
|
|
|
2003 |
|
S |
p. S19-S20 2 p. |
artikel |
39 |
Parallel Speaker Sessions
|
|
|
2004 |
|
S |
p. S7-S30 24 p. |
artikel |
40 |
Plenary Lectures
|
|
|
2003 |
|
S |
p. S1- 1 p. |
artikel |
41 |
Plenary Presentations
|
|
|
2004 |
|
S |
p. S1-S5 5 p. |
artikel |
42 |
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients
|
Nardotto, Glauco H.B. |
|
2017 |
|
S |
p. S108-S115 8 p. |
artikel |
43 |
Population pharmacokinetics of NNZ-2566 in healthy subjects
|
Oosterholt, Sean P. |
|
2017 |
|
S |
p. S98-S107 10 p. |
artikel |
44 |
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects
|
Antunes, Natalicia de Jesus |
|
2017 |
|
S |
p. S116-S123 8 p. |
artikel |
45 |
Posters
|
|
|
2003 |
|
S |
p. S21-S42 22 p. |
artikel |
46 |
Posters
|
|
|
2004 |
|
S |
p. S31-S78 48 p. |
artikel |
47 |
The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation
|
de Witte, W.E.A. |
|
2017 |
|
S |
p. S83-S89 7 p. |
artikel |
48 |
Towards personalized treatment of pain using a quantitative systems pharmacology approach
|
Goulooze, Sebastiaan C. |
|
2017 |
|
S |
p. S32-S38 7 p. |
artikel |
49 |
Use of mathematics to guide target selection in systems pharmacology; application to receptor tyrosine kinase (RTK) pathways
|
Benson, Neil |
|
2017 |
|
S |
p. S140-S148 9 p. |
artikel |
50 |
XVII Helsinki University Congress of Drug Research
|
|
|
2003 |
|
S |
p. vii-xiii nvt p. |
artikel |